Publication | Closed Access

Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT

Adaptive RadiotherapyRadiation TherapyMedicineRadionuclide TherapyMetachronous OligometastasesRadiopharmaceutical TherapyOncologyRadiation OncologyNuclear MedicineRadiologyHealth Sciences